Soluble ST2 as a Potential Biomarker for Risk Assessment of Pulmonary Hypertension in Patients Undergoing TAVR?

Elke Boxhammer (First author), Moritz Mirna (Co-author), Laura Bäz, Nina Bacher (Co-author), Albert Topf (Co-author), Brigitte Sipos (Co-author), Marcus Franz, Daniel Kretzschmar, Uta Hoppe (Co-author), Alexander Lauten, Michael Lichtenauer* (Last author)

*Corresponding author for this work

Research output: Contribution to journalOriginal Articlepeer-review

4 Citations (Web of Science)
Original languageEnglish
JournalLIFE-BASEL
Volume12
Issue number3
DOIs
Publication statusPublished - 2022

Keywords

  • AORTIC-VALVE-REPLACEMENT
  • HEART-FAILURE
  • MORTALITY
  • PREDICTION
  • STENOSIS
  • IMPACT
  • IMPLANTATION
  • SUPPRESSION
  • SURVIVAL
  • OUTCOMES

Cite this